183 related articles for article (PubMed ID: 17728042)
21. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.
Chaudhary KR; Cho WJ; Yang F; Samokhvalov V; El-Sikhry HE; Daniel EE; Seubert JM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):258-63. PubMed ID: 23403888
[TBL] [Abstract][Full Text] [Related]
22. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
[TBL] [Abstract][Full Text] [Related]
23. Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione Reductase.
Hayashida K; Bagchi A; Miyazaki Y; Hirai S; Seth D; Silverman MG; Rezoagli E; Marutani E; Mori N; Magliocca A; Liu X; Berra L; Hindle AG; Donnino MW; Malhotra R; Bradley MO; Stamler JS; Ichinose F
Circulation; 2019 Feb; 139(6):815-827. PubMed ID: 30586713
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive study of survival, tissue damage, and neurological dysfunction in a murine model of cardiopulmonary resuscitation after potassium-induced cardiac arrest.
Menzebach A; Bergt S; von Waldthausen P; Dinu C; Nöldge-Schomburg G; Vollmar B
Shock; 2010 Feb; 33(2):189-96. PubMed ID: 19487971
[TBL] [Abstract][Full Text] [Related]
25. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
Bettaieb A; Koike S; Chahed S; Zhao Y; Bachaalany S; Hashoush N; Graham J; Fatima H; Havel PJ; Gruzdev A; Zeldin DC; Hammock BD; Haj FG
FEBS J; 2017 Jul; 284(13):1970-1986. PubMed ID: 28485854
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
Hoopes SL; Gruzdev A; Edin ML; Graves JP; Bradbury JA; Flake GP; Lih FB; DeGraff LM; Zeldin DC
PLoS One; 2017; 12(4):e0175348. PubMed ID: 28384353
[TBL] [Abstract][Full Text] [Related]
27. Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury.
Jamieson KL; Darwesh AM; Sosnowski DK; Zhang H; Shah S; Zhabyeyev P; Yang J; Hammock BD; Edin ML; Zeldin DC; Oudit GY; Kassiri Z; Seubert JM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567578
[TBL] [Abstract][Full Text] [Related]
28. Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.
Ni GH; Chen JF; Chen XP; Yang TL
Pharmazie; 2011 Mar; 66(3):153-7. PubMed ID: 21553642
[TBL] [Abstract][Full Text] [Related]
29. Sexually dimorphic phenotype of arteriolar responsiveness to shear stress in soluble epoxide hydrolase-knockout mice.
Qin J; Kandhi S; Froogh G; Jiang H; Luo M; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1860-6. PubMed ID: 26453332
[TBL] [Abstract][Full Text] [Related]
30. Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury.
Liu LP; Li B; Shuai TK; Zhu L; Li YM
BMC Anesthesiol; 2018 Apr; 18(1):48. PubMed ID: 29703148
[TBL] [Abstract][Full Text] [Related]
31. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
[TBL] [Abstract][Full Text] [Related]
32. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model.
Batchu SN; Law E; Brocks DR; Falck JR; Seubert JM
J Mol Cell Cardiol; 2009 Jan; 46(1):67-74. PubMed ID: 18973759
[TBL] [Abstract][Full Text] [Related]
33. Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis.
Vanella L; Canestraro M; Lee CR; Cao J; Zeldin DC; Schwartzman ML; Abraham NG
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():139-47. PubMed ID: 25908301
[TBL] [Abstract][Full Text] [Related]
34. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.
Luria A; Bettaieb A; Xi Y; Shieh GJ; Liu HC; Inoue H; Tsai HJ; Imig JD; Haj FG; Hammock BD
Proc Natl Acad Sci U S A; 2011 May; 108(22):9038-43. PubMed ID: 21571638
[TBL] [Abstract][Full Text] [Related]
35. Soluble epoxide hydrolase: a new target for cardioprotection.
Gross GJ; Nithipatikom K
Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.
Keserü B; Barbosa-Sicard E; Schermuly RT; Tanaka H; Hammock BD; Weissmann N; Fisslthaler B; Fleming I
Cardiovasc Res; 2010 Jan; 85(1):232-40. PubMed ID: 19679679
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
[TBL] [Abstract][Full Text] [Related]
39. Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase.
Bianco RA; Agassandian K; Cassell MD; Spector AA; Sigmund CD
Brain Res; 2009 Sep; 1291():60-72. PubMed ID: 19643090
[TBL] [Abstract][Full Text] [Related]
40. Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner.
Ikeda M; Swide T; Vayl A; Lahm T; Anderson S; Hutchens MP
Crit Care; 2015 Sep; 19(1):332. PubMed ID: 26384003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
